Amrutanjan Health Care Limited has submitted a regulatory disclosure to the National Stock Exchange of India Limited and BSE Limited regarding an upcoming board meeting.
The Board of Directors meeting is scheduled to be held on Tuesday, 11th August, 2026 at Hyderabad. The primary agenda item is to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026 (Q1 FY27), along with the Limited Review Report by the Statutory Auditors.
The company also confirmed that the Trading Window for dealing in equity shares of the Company remains closed, as previously communicated via letter dated 24th June 2026. The closure is effective from 1st July, 2026 and will continue until 13th August 2026. This trading restriction is implemented pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with the Company's Code of Conduct for regulating, monitoring and reporting trading in securities.
The disclosure is made under Regulation 29(1) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The communication is signed by Gagan Preet Singh, General Manager - Legal, Company Secretary & Compliance Officer, on behalf of Amrutanjan Health Care Limited.